{"data":{"id":2231,"citation":"Thoma G, Beerli C, Bigaud M, Bruns C, Cooke NG, Streiff MB, Zerwes HG.: Reduced cardiac side-effect potential by introduction of polar groups: discovery of NIBR-1282, an orally bioavailable CCR5 antagonist which is active in vivo. Bioorg Med Chem Lett, Volume 18 (6), 2008","title":"Reduced cardiac side-effect potential by introduction of polar groups: discovery of NIBR-1282, an orally bioavailable CCR5 antagonist which is active in vivo.","doi":"10.1016\/j.bmcl.2008.01.108","doi_url":"https:\/\/doi.org\/10.1016\/j.bmcl.2008.01.108","pmid":"18267361","pmid_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/18267361\/","year":2008,"journal":"Bioorg Med Chem Lett","volume":"18","issue":"6","page":"2000-2005","authors":[{"first_name":"Beerli C","last_name":null,"full_name":null},{"first_name":"Bigaud M","last_name":null,"full_name":null},{"first_name":"Bruns C","last_name":null,"full_name":null},{"first_name":"Cooke NG","last_name":null,"full_name":null},{"first_name":"Streiff MB","last_name":null,"full_name":null},{"first_name":"Thoma G","last_name":null,"full_name":null},{"first_name":"Zerwes HG.","last_name":null,"full_name":null}],"url":"https:\/\/molmedb.upol.cz\/api\/v1\/publications\/2231","landing_page":"https:\/\/molmedb.upol.cz\/publication\/2231","created_at":"2023-06-23T10:10:37.000000Z","updated_at":null}}